Immediate and six months clinical and angiographic results of intracoronary Ephesos stent implantation: the "Ephesos-1" study

Basit Öğe Kaydı
dc.contributor.authorUyan, Cihangir
dc.contributor.authorAkdemir, Ramazan
dc.contributor.authorGündüz , Hüseyin
dc.contributor.authorÖzhan, Hakan
dc.contributor.authorArınç, Hüseyin
dc.date.accessioned2020-04-30T23:18:25Z
dc.date.available2020-04-30T23:18:25Z
dc.date.issued2005
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionWOS: 000228734900007en_US
dc.descriptionPubMed: 15887475en_US
dc.description.abstractBackground - This study was conducted to evaluate the clinical and angiographic results of the Ephesos stent implantation in patients with symptomatic coronary artery disease. The Ephesos stent is a new balloon-expandable, stainless steel, tubular stent with multicellular design. Methods - One hundred ten patients with native coronary artery disease were included in the study. The Ephesos stents were implanted in 163 de novo lesions detected in these patients. Immediate and long-term clinical and angiographic follow-up results were evaluated. Results - Most of the patients had unstable angina 63.6%, and 36.7 % of the lesions were type B and C. Mean lesion length was 12.7 +/- 4.7. In 62% of the patients the reference lumen diameter was < 3 mm. One Q-wave and one non-Q-wave myocardial infarction (MI) occurred due to acute thrombotic occlusion during hospital stay. The 6-month event-free survival rate was 77.3%. No patients died in the six-month follow-up period, but 2 patients had non-Q wave MI and I patient experienced Q-wave MI within this period. Control angiographic data was collected from I 10 patients (100% of patients and a total of 163 lesions). Angiographic restenosis rate was 18.1 %. Twenty-two patients with restenosis had repeated target lesion balloon dilatation. Conclusion -The results of the present study showed that the Ephesos stent is a safe and effective choice with a low incidence of major adverse cardiac events and restenosis rate within six months of follow-up.en_US
dc.identifier.doi10.2143/AC.60.2.2005030
dc.identifier.endpage190en_US
dc.identifier.issn0001-5385
dc.identifier.issn1784-973X
dc.identifier.issue2en_US
dc.identifier.startpage185en_US
dc.identifier.urihttps://doi.org/10.2143/AC.60.2.2005030
dc.identifier.urihttps://hdl.handle.net/20.500.12684/3282
dc.identifier.volume60en_US
dc.identifier.wosWOS:000228734900007en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofActa Cardiologicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEphesos stenten_US
dc.subjectevent-free survivalen_US
dc.subjectrestenosisen_US
dc.titleImmediate and six months clinical and angiographic results of intracoronary Ephesos stent implantation: the "Ephesos-1" studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu